jRCT1080223928CompletedN/a
One year follow-up study of healthy adults who received one injection of live attenuated varicella vaccine
The Research Foundation For Microbial Diseases of Osaka University1 site80 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- N/a
- Status
- Completed
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- -
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 50age old over to No limit (—)
- Sex
- All
Inclusion Criteria
- •volunteers who participated in previous VZV vaccine study (JAPIC CTI-173532)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
-
exploratory Flowcytometric analyses of VZV CD4 memory cell response
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Unknown
One year follow-up study of healthy adults who received one injection of live attenuated varicella vaccineprotection against Herpes ZosterJPRN-jRCT1080223928The Research Foundation For Microbial Diseases of Osaka University80
Active, not recruiting
Not Applicable
A Prospective Longitudinal Study in Adult Patients With Multifocal Motor Neuropathy (iMMersioN)jRCT1030240145argenx BV6
Not yet recruiting
Not Applicable
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study (EXPEDITION)jRCT2053240056Sarepta Therapeutics, Inc.10
Completed
Phase 1
Safety study of an improved aluminium-free Hepatitis B vaccine based on a natural plant sugarHepatitis B preventionInfection - Other infectious diseasesPublic Health - EpidemiologyACTRN12607000598482Vaxine Pty Ltd24
Completed
Not Applicable
A non-interventional observational study in adults assessing the safety and tolerability of AVANZ® in case of concomitant specific immunotherapy (SCIT/AIT/SLIT)J30.1J30.3Allergic rhinitis due to pollenOther allergic rhinitisDRKS00005030ALK-Abelló Arzneimittel GmbH311